<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37139492</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>05</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>11</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2235-2988</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in cellular and infection microbiology</Title><ISOAbbreviation>Front Cell Infect Microbiol</ISOAbbreviation></Journal><ArticleTitle>Coxsackievirus B3 infects and disrupts human induced-pluripotent stem cell derived brain-like endothelial cells.</ArticleTitle><Pagination><StartPage>1171275</StartPage><MedlinePgn>1171275</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1171275</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcimb.2023.1171275</ELocationID><Abstract><AbstractText>Coxsackievirus B3 (CVB3) is a significant human pathogen that is commonly found worldwide. CVB3 among other enteroviruses, are the leading causes of aseptic meningo-encephalitis which can be fatal especially in young children. How the virus gains access to the brain is poorly-understood, and the host-virus interactions that occur at the blood-brain barrier (BBB) is even less-characterized. The BBB is a highly specialized biological barrier consisting primarily of brain endothelial cells which possess unique barrier properties and facilitate the passage of nutrients into the brain while restricting access to toxins and pathogens including viruses. To determine the effects of CVB3 infection on the BBB, we utilized a model of human induced-pluripotent stem cell-derived brain-like endothelial cells (iBECs) to ascertain if CVB3 infection may alter barrier cell function and overall survival. In this study, we determined that these iBECs indeed are susceptible to CVB3 infection and release high titers of extracellular virus. We also determined that infected iBECs maintain high transendothelial electrical resistance (TEER) during early infection despite possessing high viral load. TEER progressively declines at later stages of infection. Interestingly, despite the high viral burden and TEER disruptions at later timepoints, infected iBEC monolayers remain intact, indicating a low degree of late-stage virally-mediated cell death, which may contribute to prolonged viral shedding. We had previously reported that CVB3 infections rely on the activation of transient receptor vanilloid potential 1 (TRPV1) and found that inhibiting TRPV1 activity with SB-366791 significantly limited CVB3 infection of HeLa cervical cancer cells. Similarly in this study, we observed that treating iBECs with SB-366791 significantly reduced CVB3 infection, which suggests that not only can this drug potentially limit viral entry into the brain, but also demonstrates that this infection model could be a valuable platform for testing antiviral treatments of neurotropic viruses. In all, our findings elucidate the unique effects of CVB3 infection on the BBB and shed light on potential mechanisms by which the virus can initiate infections in the brain.</AbstractText><CopyrightInformation>Copyright © 2023 Mamana, Humber, Espinal, Seo, Vollmuth, Sin and Kim.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mamana</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, University of Alabama, Tuscaloosa, AL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Humber</LastName><ForeName>Gabrielle M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, University of Alabama, Tuscaloosa, AL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Espinal</LastName><ForeName>Eric R</ForeName><Initials>ER</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, University of Alabama, Tuscaloosa, AL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seo</LastName><ForeName>Soojung</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, University of Alabama, Tuscaloosa, AL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vollmuth</LastName><ForeName>Nadine</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, University of Alabama, Tuscaloosa, AL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sin</LastName><ForeName>Jon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, University of Alabama, Tuscaloosa, AL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Brandon J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, University of Alabama, Tuscaloosa, AL, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Convergent Biosciences and Medicine, University of Alabama, Tuscaloosa, AL, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Alabama Life Research Institute, University of Alabama, Tuscaloosa, AL, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 DK125692</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AI145356</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cell Infect Microbiol</MedlineTA><NlmUniqueID>101585359</NlmUniqueID><ISSNLinking>2235-2988</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042783" MajorTopicYN="N">Endothelial Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="Y">Coxsackievirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039904" MajorTopicYN="Y">Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">blood brain barrier</Keyword><Keyword MajorTopicYN="N">brain</Keyword><Keyword MajorTopicYN="N">coxsackievirus B3</Keyword><Keyword MajorTopicYN="N">stem cells</Keyword><Keyword MajorTopicYN="N">virus</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>5</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>4</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>4</Day><Hour>2</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37139492</ArticleId><ArticleId IdType="pmc">PMC10149843</ArticleId><ArticleId IdType="doi">10.3389/fcimb.2023.1171275</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abbott N. J., Patabendige A. A., Dolman D. E., Yusof S. R., Begley D. J. (2010). Structure and function of the blood-brain barrier. Neurobiol. Dis. 37, 13–25. doi: 10.1016/j.nbd.2009.07.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2009.07.030</ArticleId><ArticleId IdType="pubmed">19664713</ArticleId></ArticleIdList></Reference><Reference><Citation>Alimonti J. B., Ribecco-Lutkiewicz M., Sodja C., Jezierski A., Stanimirovic D. B., Liu Q., et al. . (2018). Zika virus crosses an in vitro human blood brain barrier model. Fluids Barriers CNS 15, 15. doi: 10.1186/s12987-018-0100-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12987-018-0100-y</ArticleId><ArticleId IdType="pmc">PMC5952854</ArticleId><ArticleId IdType="pubmed">29759080</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Obaidi M. M. J., Bahadoran A., Wang S. M., Manikam R., Raju C. S., Sekaran S. D. (2018). Disruption of the blood brain barrier is vital property of neurotropic viral infection of the central nervous system. Acta Virol. 62, 16–27. doi: 10.4149/av_2018_102</Citation><ArticleIdList><ArticleId IdType="doi">10.4149/av_2018_102</ArticleId><ArticleId IdType="pubmed">29521099</ArticleId></ArticleIdList></Reference><Reference><Citation>Appelt-Menzel A., Cubukova A., Günther K., Edenhofer F., Piontek J., Krause G., et al. . (2017). Establishment of a human blood-brain barrier Co-culture model mimicking the neurovascular unit using induced pluri- and multipotent stem cells. Stem Cell Rep. 8, 894–906. doi: 10.1016/j.stemcr.2017.02.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.02.021</ArticleId><ArticleId IdType="pmc">PMC5390136</ArticleId><ArticleId IdType="pubmed">28344002</ArticleId></ArticleIdList></Reference><Reference><Citation>Auvinen P., Hyypiä T. (1990). Echoviruses include genetically distinct serotypes. J. Gen. Virol. 71 (Pt 9), 2133–2139. doi: 10.1099/0022-1317-71-9-2133</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-71-9-2133</ArticleId><ArticleId IdType="pubmed">2170575</ArticleId></ArticleIdList></Reference><Reference><Citation>Beale A. J., Duncan D., Stackiw W., Davis N., Dempster G., Rhodes A. J. (1956). Further observations on the laboratory diagnosis of aseptic meningitis caused by group b coxsackie virus. Can. J. Public Health 47, 179–186.</Citation><ArticleIdList><ArticleId IdType="pubmed">13316644</ArticleId></ArticleIdList></Reference><Reference><Citation>Benschop K. S. M., Broberg E. K., Hodcroft E., Schmitz D., Albert J., Baicus A., et al. . (2021). Molecular epidemiology and evolutionary trajectory of emerging echovirus 30, Europe. Emerg. Infect. Dis. 27, 1616–1626. doi: 10.3201/eid2706.203096</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2706.203096</ArticleId><ArticleId IdType="pmc">PMC8153861</ArticleId><ArticleId IdType="pubmed">34013874</ArticleId></ArticleIdList></Reference><Reference><Citation>Berlin L. E., Rorabaugh M. L., Heldrich F., Roberts K., Doran T., Modlin J. F. (1993). Aseptic meningitis in infants &lt; 2 years of age: diagnosis and etiology. J. Infect. Dis. 168, 888–892. doi: 10.1093/infdis/168.4.888</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/168.4.888</ArticleId><ArticleId IdType="pubmed">8397269</ArticleId></ArticleIdList></Reference><Reference><Citation>Calderón-Peláez M. A., Velandia-Romero M. L., Bastidas-Legarda L. Y., Beltrán E. O., Camacho-Ortega S. J., Castellanos J. E. (2019). Dengue virus infection of blood-brain barrier cells: Consequences of severe disease. Front. Microbiol. 10, 1435. doi: 10.3389/fmicb.2019.01435</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2019.01435</ArticleId><ArticleId IdType="pmc">PMC6606788</ArticleId><ArticleId IdType="pubmed">31293558</ArticleId></ArticleIdList></Reference><Reference><Citation>Canfield S. G., Stebbins M. J., Faubion M. G., Gastfriend B. D., Palecek S. P., Shusta E. V. (2019). An isogenic neurovascular unit model comprised of human induced pluripotent stem cell-derived brain microvascular endothelial cells, pericytes, astrocytes, and neurons. Fluids Barriers CNS 16, 25. doi: 10.1186/s12987-019-0145-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12987-019-0145-6</ArticleId><ArticleId IdType="pmc">PMC6685239</ArticleId><ArticleId IdType="pubmed">31387594</ArticleId></ArticleIdList></Reference><Reference><Citation>Canfield S. G., Stebbins M. J., Morales B. S., Asai S. W., Vatine G. D., Svendsen C. N., et al. . (2017). An isogenic blood-brain barrier model comprising brain endothelial cells, astrocytes, and neurons derived from human induced pluripotent stem cells. J. Neurochem. 140, 874–888. doi: 10.1111/jnc.13923</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13923</ArticleId><ArticleId IdType="pmc">PMC5339046</ArticleId><ArticleId IdType="pubmed">27935037</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrol E. D., Beadsworth M. B., Jenkins N., Ratcliffe L., Ashton I., Crowley B., et al. . (2006). Clinical and diagnostic findings of an echovirus meningitis outbreak in the north west of England. Postgrad Med. J., 82 60–64,. doi: 10.1136/pgmj.2005.036608</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/pgmj.2005.036608</ArticleId><ArticleId IdType="pmc">PMC2563715</ArticleId><ArticleId IdType="pubmed">16397083</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman N. M., Kim K. S. (2008). Persistent coxsackievirus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy. Curr. Top. Microbiol. Immunol. 323, 275–292. doi: 10.1007/978-3-540-75546-3_13</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-540-75546-3_13</ArticleId><ArticleId IdType="pubmed">18357775</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y. H., Du W., Hagemeijer M. C., Takvorian P. M., Pau C., Cali A., et al. . (2015). Phosphatidylserine vesicles enable efficient en bloc transmission of enteroviruses. Cell 160, 619–630. doi: 10.1016/j.cell.2015.01.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.01.032</ArticleId><ArticleId IdType="pmc">PMC6704014</ArticleId><ArticleId IdType="pubmed">25679758</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z., Li G. (2021). Immune response and blood-brain barrier dysfunction during viral neuroinvasion. Innate Immun. 27, 109–117. doi: 10.1177/1753425920954281</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1753425920954281</ArticleId><ArticleId IdType="pmc">PMC7882805</ArticleId><ArticleId IdType="pubmed">32903111</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y., Medina A., Yao Z., Basu M., Natekar J. P., Lang J., et al. . (2022). Intrinsic antiviral immunity of barrier cells revealed by an iPSC-derived blood-brain barrier cellular model. Cell Rep. 39, 110885. doi: 10.1016/j.celrep.2022.110885</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2022.110885</ArticleId><ArticleId IdType="pmc">PMC9230077</ArticleId><ArticleId IdType="pubmed">35649379</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne C. B., Shen L., Turner J. R., Bergelson J. M. (2007). Coxsackievirus entry across epithelial tight junctions requires occludin and the small GTPases Rab34 and Rab5. Cell Host Microbe 2, 181–192. doi: 10.1016/j.chom.2007.07.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2007.07.003</ArticleId><ArticleId IdType="pmc">PMC2719558</ArticleId><ArticleId IdType="pubmed">18005733</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahllund L., Nissinen L., Pulli T., Hyttinen V. P., Stanway G., Hyypiä T. (1995). The genome of echovirus 11. Virus Res. 35, 215–222. doi: 10.1016/0168-1702(94)00104-K</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0168-1702(94)00104-K</ArticleId><ArticleId IdType="pubmed">7762294</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahm T., Adams O., Boettcher S., Diedrich S., Morozov V., Hansman G., et al. . (2018). Strain-dependent effects of clinical echovirus 30 outbreak isolates at the blood-CSF barrier. J. Neuroinflamm. 15, 50. doi: 10.1186/s12974-018-1061-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-018-1061-4</ArticleId><ArticleId IdType="pmc">PMC5819246</ArticleId><ArticleId IdType="pubmed">29463289</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahm T., Frank F., Adams O., Lindner H. A., Ishikawa H., Weiss C., et al. . (2017). Sequential transmigration of polymorphonuclear cells and naive CD3(+) T lymphocytes across the blood-cerebrospinal-fluid barrier in vitro following infection with echovirus 30. Virus Res. 232, 54–62. doi: 10.1016/j.virusres.2017.01.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2017.01.024</ArticleId><ArticleId IdType="pubmed">28161477</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejana E., Orsenigo F., Molendini C., Baluk P., Mcdonald D. M. (2009). Organization and signaling of endothelial cell-to-cell junctions in various regions of the blood and lymphatic vascular trees. Cell Tissue Res. 335, 17–25. doi: 10.1007/s00441-008-0694-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-008-0694-5</ArticleId><ArticleId IdType="pmc">PMC4422058</ArticleId><ArticleId IdType="pubmed">18855014</ArticleId></ArticleIdList></Reference><Reference><Citation>Derk J., Como C. N., Jones H. E., Joyce L. R., Bonney S., O’rourke R., et al. . (2022). ‘Formation and function of the meninges arachnoid barrier around the developing brain’. bioRxiv. doi: 10.1101/2022.06.10.495709</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.06.10.495709</ArticleId><ArticleId IdType="pmc">PMC10231667</ArticleId><ArticleId IdType="pubmed">36996816</ArticleId></ArticleIdList></Reference><Reference><Citation>Doran K. S., Engelson E. J., Khosravi A., Maisey H. C., Fedtke I., Equils O., et al. . (2005). Blood-brain barrier invasion by group b streptococcus depends upon proper cell-surface anchoring of lipoteichoic acid. J. Clin. Invest. 115, 2499–2507. doi: 10.1172/JCI23829</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI23829</ArticleId><ArticleId IdType="pmc">PMC1193870</ArticleId><ArticleId IdType="pubmed">16138192</ArticleId></ArticleIdList></Reference><Reference><Citation>Endres L. M., Jungblut M., Divyapicigil M., Sauer M., Stigloher C., Christodoulides M., et al. . (2022). Development of a multicellular in vitro model of the meningeal blood-CSF barrier to study neisseria meningitidis infection. Fluids Barriers CNS 19, 81. doi: 10.1186/s12987-022-00379-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12987-022-00379-z</ArticleId><ArticleId IdType="pmc">PMC9597984</ArticleId><ArticleId IdType="pubmed">36289516</ArticleId></ArticleIdList></Reference><Reference><Citation>Endres L. M., Schubert-Unkmeir A., Kim B. J. (2020). Neisseria meningitidis infection of induced pluripotent stem-cell derived brain endothelial cells. J. Vis. Exp. doi: 10.3791/61400</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/61400</ArticleId><ArticleId IdType="pubmed">32744533</ArticleId></ArticleIdList></Reference><Reference><Citation>Enzmann G., Kargaran S., Engelhardt B. (2018). Ischemia-reperfusion injury in stroke: impact of the brain barriers and brain immune privilege on neutrophil function. Ther. Adv. Neurol. Disord. 11, 1756286418794184. doi: 10.1177/1756286418794184</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1756286418794184</ArticleId><ArticleId IdType="pmc">PMC6111395</ArticleId><ArticleId IdType="pubmed">30181779</ArticleId></ArticleIdList></Reference><Reference><Citation>Erickson M. A., Rhea E. M., Knopp R. C., Banks W. A. (2021). Interactions of SARS-CoV-2 with the blood-brain barrier. Int. J. Mol. Sci. 22, 2681. doi: 10.3390/ijms22052681</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22052681</ArticleId><ArticleId IdType="pmc">PMC7961671</ArticleId><ArticleId IdType="pubmed">33800954</ArticleId></ArticleIdList></Reference><Reference><Citation>Espinal E. R., Matthews T., Holder B. M., Bee O. B., Humber G. M., Brook C. E., et al. . (2022. a). Group b streptococcus-induced macropinocytosis contributes to bacterial invasion of brain endothelial cells. Pathogens 11 (4), 474. doi: 10.3390/pathogens11040474</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11040474</ArticleId><ArticleId IdType="pmc">PMC9028350</ArticleId><ArticleId IdType="pubmed">35456149</ArticleId></ArticleIdList></Reference><Reference><Citation>Espinal E. R., Sharp S. J., Kim B. J. (2022. b). Induced pluripotent stem cell (iPSC)-derived endothelial cells to study bacterial-brain endothelial cell interactions. Methods Mol. Biol. 2492, 73–101. doi: 10.1007/978-1-0716-2289-6_4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-0716-2289-6_4</ArticleId><ArticleId IdType="pubmed">35733039</ArticleId></ArticleIdList></Reference><Reference><Citation>Falangola M. F., Hanly A., Galvao-Castro B., Petito C. K. (1995). HIV Infection of human choroid plexus: a possible mechanism of viral entry into the CNS. J. Neuropathol. Exp. Neurol. 54, 497–503. doi: 10.1097/00005072-199507000-00003</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-199507000-00003</ArticleId><ArticleId IdType="pubmed">7602324</ArticleId></ArticleIdList></Reference><Reference><Citation>Feuer R., Mena I., Pagarigan R. R., Harkins S., Hassett D. E., Whitton J. L. (2003). Coxsackievirus B3 and the neonatal CNS: the roles of stem cells, developing neurons, and apoptosis in infection, viral dissemination, and disease. Am. J. Pathol. 163, 1379–1393. doi: 10.1016/S0002-9440(10)63496-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9440(10)63496-7</ArticleId><ArticleId IdType="pmc">PMC1868316</ArticleId><ArticleId IdType="pubmed">14507646</ArticleId></ArticleIdList></Reference><Reference><Citation>Germano J. F., Sawaged S., Saadaeijahromi H., Andres A. M., Feuer R., Gottlieb R. A., et al. . (2019). Coxsackievirus b infection induces the extracellular release of miR-590-5p, a proviral microRNA. Virology 529, 169–176. doi: 10.1016/j.virol.2019.01.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2019.01.025</ArticleId><ArticleId IdType="pmc">PMC6382511</ArticleId><ArticleId IdType="pubmed">30711774</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu J., Zhao Y., Wu J., Chen Y., Yin Y., Jia X., et al. . (2023). Enterovirus-71 utilizes small extracellular vesicles to cross the blood-brain barrier for infecting the central nervous system via transcytosis. J. Med. Virol. 95 (1). doi: 10.1002/jmv.28120</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28120</ArticleId><ArticleId IdType="pubmed">36056524</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms H. C., Abbott N. J., Burek M., Cecchelli R., Couraud P. O., Deli M. A., et al. . (2016). In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use. J. Cereb Blood Flow Metab. 36, 862–890. doi: 10.1177/0271678X16630991</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0271678X16630991</ArticleId><ArticleId IdType="pmc">PMC4853841</ArticleId><ArticleId IdType="pubmed">26868179</ArticleId></ArticleIdList></Reference><Reference><Citation>Henquell C., Chambon M., Bailly J. L., Alcaraz S., De Champs C., Archimbaud C., et al. . (2001). Prospective analysis of 61 cases of enteroviral meningitis: interest of systematic genome detection in cerebrospinal fluid irrespective of cytologic examination results. J. Clin. Virol. 21, 29–35. doi: 10.1016/S1386-6532(00)00176-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1386-6532(00)00176-1</ArticleId><ArticleId IdType="pubmed">11255095</ArticleId></ArticleIdList></Reference><Reference><Citation>Horstmann D. M. (1965). ENTEROVIRUS INFECTIONS: ETIOLOGIC, EPIDEMIOLOGIC AND CLINICAL ASPECTS. Calif Med. 103, 1–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1516118</ArticleId><ArticleId IdType="pubmed">14336786</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H. I., Lin J. Y., Chiang H. C., Huang P. N., Lin Q. D., Shih S. R. (2020). Exosomes facilitate transmission of enterovirus A71 from human intestinal epithelial cells. J. Infect. Dis. 222, 456–469. doi: 10.1093/infdis/jiaa174</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa174</ArticleId><ArticleId IdType="pmc">PMC7336570</ArticleId><ArticleId IdType="pubmed">32271384</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber S., Ramsingh A. I. (2004). Coxsackievirus-induced pancreatitis. Viral Immunol. 17, 358–369. doi: 10.1089/vim.2004.17.358</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2004.17.358</ArticleId><ArticleId IdType="pubmed">15357902</ArticleId></ArticleIdList></Reference><Reference><Citation>Huttunen P., Santti J., Pulli T., Hyypiä T. (1996). The major echovirus group is genetically coherent and related to coxsackie b viruses. J. Gen. Virol. 77 (Pt 4), 715–725. doi: 10.1099/0022-1317-77-4-715</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-77-4-715</ArticleId><ArticleId IdType="pubmed">8627260</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivey N. S., Maclean A. G., Lackner A. A. (2009). Acquired immunodeficiency syndrome and the blood-brain barrier. J. Neurovirol 15, 111–122. doi: 10.1080/13550280902769764</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13550280902769764</ArticleId><ArticleId IdType="pmc">PMC2744422</ArticleId><ArticleId IdType="pubmed">19306229</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob F., Pather S. R., Huang W. K., Zhang F., Wong S. Z. H., Zhou H., et al. . (2020). Human pluripotent stem cell-derived neural cells and brain organoids reveal SARS-CoV-2 neurotropism predominates in choroid plexus epithelium. Cell Stem Cell 27, 937–950.e9. doi: 10.1016/j.stem.2020.09.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7505550</ArticleId><ArticleId IdType="pubmed">33010822</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadry H., Noorani B., Cucullo L. (2020). A blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids Barriers CNS 17, 69. doi: 10.1186/s12987-020-00230-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12987-020-00230-3</ArticleId><ArticleId IdType="pmc">PMC7672931</ArticleId><ArticleId IdType="pubmed">33208141</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J., Alejandro B., Hetman M., Hattab E. M., Joiner J., Schroten H., et al. . (2020). Zika virus infects pericytes in the choroid plexus and enters the central nervous system through the blood-cerebrospinal fluid barrier. PloS Pathog. 16, e1008204. doi: 10.1371/journal.ppat.1008204</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008204</ArticleId><ArticleId IdType="pmc">PMC7194358</ArticleId><ArticleId IdType="pubmed">32357162</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim B. J., Bee O. B., Mcdonagh M. A., Stebbins M. J., Palecek S. P., Doran K. S., et al. . (2017). Modeling group b streptococcus and blood-brain barrier interaction by using induced pluripotent stem cell-derived brain endothelial cells. mSphere 2 (6), e00398-17. doi: 10.1128/mSphere.00398-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mSphere.00398-17</ArticleId><ArticleId IdType="pmc">PMC5663983</ArticleId><ArticleId IdType="pubmed">29104935</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim B. J., Hancock B. M., Bermudez A., Del Cid N., Reyes E., Van Sorge N. M., et al. . (2015). Bacterial induction of Snail1 contributes to blood-brain barrier disruption. J. Clin. Invest. 125, 2473–2483. doi: 10.1172/JCI74159</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI74159</ArticleId><ArticleId IdType="pmc">PMC4497739</ArticleId><ArticleId IdType="pubmed">25961453</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim B. J., Mcdonagh M. A., Deng L., Gastfriend B. D., Schubert-Unkmeir A., Doran K. S., et al. . (2019. a). Streptococcus agalactiae disrupts p-glycoprotein function in brain endothelial cells. Fluids Barriers CNS 16, 26. doi: 10.1186/s12987-019-0146-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12987-019-0146-5</ArticleId><ArticleId IdType="pmc">PMC6704684</ArticleId><ArticleId IdType="pubmed">31434575</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim B. J., Shusta E. V., Doran K. S. (2019. b). Past and current perspectives in modeling bacteria and blood-brain barrier interactions. Front. Microbiol. 10 1336. doi: 10.3389/fmicb.2019.01336</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2019.01336</ArticleId><ArticleId IdType="pmc">PMC6585309</ArticleId><ArticleId IdType="pubmed">31263460</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasemann S., Haferkamp U., Pfefferle S., Woo M. S., Heinrich F., Schweizer M., et al. . (2022). The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2. Stem Cell Rep. 17, 307–320. doi: 10.1016/j.stemcr.2021.12.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2021.12.011</ArticleId><ArticleId IdType="pmc">PMC8772030</ArticleId><ArticleId IdType="pubmed">35063125</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauer A. N., Tenenbaum T., Schroten H., Schwerk C. (2018). The diverse cellular responses of the choroid plexus during infection of the central nervous system. Am. J. Physiol. Cell Physiol. 314, C152–c165. doi: 10.1152/ajpcell.00137.2017</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00137.2017</ArticleId><ArticleId IdType="pubmed">29070490</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippmann E. S., Azarin S. M., Kay J. E., Nessler R. A., Wilson H. K., Al-Ahmad A., et al. . (2012). Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells. Nat. Biotechnol. 30, 783–791. doi: 10.1038/nbt.2247</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.2247</ArticleId><ArticleId IdType="pmc">PMC3467331</ArticleId><ArticleId IdType="pubmed">22729031</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchi N., Granata T., Ghosh C., Janigro D. (2012). Blood-brain barrier dysfunction and epilepsy: pathophysiologic role and therapeutic approaches. Epilepsia 53, 1877–1886. doi: 10.1111/j.1528-1167.2012.03637.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1528-1167.2012.03637.x</ArticleId><ArticleId IdType="pmc">PMC4842020</ArticleId><ArticleId IdType="pubmed">22905812</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins Gomes S. F., Westermann A. J., Sauerwein T., Hertlein T., Förstner K. U., Ohlsen K., et al. . (2019). Induced pluripotent stem cell-derived brain endothelial cells as a cellular model to study neisseria meningitidis infection. Front. Microbiol. 10, 1181. doi: 10.3389/fmicb.2019.01181</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2019.01181</ArticleId><ArticleId IdType="pmc">PMC6548865</ArticleId><ArticleId IdType="pubmed">31191497</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu R., Kim B. J., Paco C., Del Rosario Y., Courtney H. S., Doran K. S. (2014). Identification of a group b streptococcal fibronectin binding protein, SfbA, that contributes to invasion of brain endothelium and development of meningitis. Infect. Immun. 82, 2276–2286. doi: 10.1128/IAI.01559-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.01559-13</ArticleId><ArticleId IdType="pmc">PMC4019170</ArticleId><ArticleId IdType="pubmed">24643538</ArticleId></ArticleIdList></Reference><Reference><Citation>Mustafá Y. M., Meuren L. M., Coelho S. V. A., De Arruda L. B. (2019). Pathways exploited by flaviviruses to counteract the blood-brain barrier and invade the central nervous system. Front. Microbiol. 10, 525. doi: 10.3389/fmicb.2019.00525</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2019.00525</ArticleId><ArticleId IdType="pmc">PMC6447710</ArticleId><ArticleId IdType="pubmed">30984122</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehra G., Bauer B., Hartz A. M. S. (2022). Blood-brain barrier leakage in alzheimer’s disease: From discovery to clinical relevance. Pharmacol. Ther. 234, 108119. doi: 10.1016/j.pharmthera.2022.108119</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2022.108119</ArticleId><ArticleId IdType="pmc">PMC9107516</ArticleId><ArticleId IdType="pubmed">35108575</ArticleId></ArticleIdList></Reference><Reference><Citation>Netanyah E., Calafatti M., Arvastsson J., Cabrera-Rode E., Cilio C. M., Sarmiento L. (2020). Extracellular vesicles released by enterovirus-infected EndoC-βH1 cells mediate non-lytic viral spread. Microorganisms 8 (11), 1753. doi: 10.3390/microorganisms8111753</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms8111753</ArticleId><ArticleId IdType="pmc">PMC7695210</ArticleId><ArticleId IdType="pubmed">33171580</ArticleId></ArticleIdList></Reference><Reference><Citation>O’hara B. A., Morris-Love J., Gee G. V., Haley S. A., Atwood W. J. (2020). JC virus infected choroid plexus epithelial cells produce extracellular vesicles that infect glial cells independently of the virus attachment receptor. PloS Pathog. 16, e1008371. doi: 10.1371/journal.ppat.1008371</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008371</ArticleId><ArticleId IdType="pmc">PMC7075641</ArticleId><ArticleId IdType="pubmed">32130281</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortiz G. G., Pacheco-Moisés F. P., Macías-Islas M., Flores-Alvarado L. J., Mireles-Ramírez M. A., González-Renovato E. D., et al. . (2014). Role of the blood-brain barrier in multiple sclerosis. Arch. Med. Res. 45, 687–697. doi: 10.1016/j.arcmed.2014.11.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcmed.2014.11.013</ArticleId><ArticleId IdType="pubmed">25431839</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan Y., Nicolazzo J. A. (2022). Altered blood-brain barrier and blood-spinal cord barrier dynamics in amyotrophic lateral sclerosis: Impact on medication efficacy and safety. Br. J. Pharmacol. 179, 2577–2588. doi: 10.1111/bph.15802</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15802</ArticleId><ArticleId IdType="pubmed">35048358</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrini L., Albecka A., Mallery D. L., Kellner M. J., Paul D., Carter A. P., et al. . (2020). SARS-CoV-2 infects the brain choroid plexus and disrupts the blood-CSF barrier in human brain organoids. Cell Stem Cell 27, 951–961.e5. doi: 10.1016/j.stem.2020.10.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2020.10.001</ArticleId><ArticleId IdType="pmc">PMC7553118</ArticleId><ArticleId IdType="pubmed">33113348</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson S. M., Tsueng G., Sin J., Mangale V., Rahawi S., Mcintyre L. L., et al. . (2014). Coxsackievirus b exits the host cell in shed microvesicles displaying autophagosomal markers. PloS Pathog. 10, e1004045. doi: 10.1371/journal.ppat.1004045</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004045</ArticleId><ArticleId IdType="pmc">PMC3983045</ArticleId><ArticleId IdType="pubmed">24722773</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotbart H. A. (2000). Viral meningitis. Semin. Neurol. 20, 277–292. doi: 10.1055/s-2000-9427</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2000-9427</ArticleId><ArticleId IdType="pubmed">11051293</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider H., Weber C. E., Schoeller J., Steinmann U., Borkowski J., Ishikawa H., et al. . (2012). Chemotaxis of T-cells after infection of human choroid plexus papilloma cells with echovirus 30 in an in vitro model of the blood-cerebrospinal fluid barrier. Virus Res. 170, 66–74. doi: 10.1016/j.virusres.2012.08.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2012.08.019</ArticleId><ArticleId IdType="pubmed">23000117</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwerk C., Tenenbaum T., Kim K. S., Schroten H. (2015). The choroid plexus-a multi-role player during infectious diseases of the CNS. Front. Cell Neurosci. 9, 80. doi: 10.3389/fncel.2015.00080</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00080</ArticleId><ArticleId IdType="pmc">PMC4357259</ArticleId><ArticleId IdType="pubmed">25814932</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo H. S., Minasov G., Seepersaud R., Doran K. S., Dubrovska I., Shuvalova L., et al. . (2013). Characterization of fibrinogen binding by glycoproteins Srr1 and Srr2 of streptococcus agalactiae. J. Biol. Chem. 288, 35982–35996. doi: 10.1074/jbc.M113.513358</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.513358</ArticleId><ArticleId IdType="pmc">PMC3861647</ArticleId><ArticleId IdType="pubmed">24165132</ArticleId></ArticleIdList></Reference><Reference><Citation>Sin J., Mcintyre L., Stotland A., Feuer R., Gottlieb R. A. (2017). Coxsackievirus b escapes the infected cell in ejected mitophagosomes. J. Virol. 91 (24), e01347-17. doi: 10.1128/JVI.01347-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01347-17</ArticleId><ArticleId IdType="pmc">PMC5709598</ArticleId><ArticleId IdType="pubmed">28978702</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh H., Koury J., Kaul M. (2021). Innate immune sensing of viruses and its consequences for the central nervous system. Viruses 13 (2), 170. doi: 10.3390/v13020170</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13020170</ArticleId><ArticleId IdType="pmc">PMC7912342</ArticleId><ArticleId IdType="pubmed">33498715</ArticleId></ArticleIdList></Reference><Reference><Citation>Slifka M. K., Pagarigan R., Mena I., Feuer R., Whitton J. L. (2001). Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection. J. Virol. 75, 2377–2387. doi: 10.1128/JVI.75.5.2377-2387.2001</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.75.5.2377-2387.2001</ArticleId><ArticleId IdType="pmc">PMC114821</ArticleId><ArticleId IdType="pubmed">11160741</ArticleId></ArticleIdList></Reference><Reference><Citation>Spitzer D., Guérit S., Puetz T., Khel M. I., Armbrust M., Dunst M., et al. . (2022). Profiling the neurovascular unit unveils detrimental effects of osteopontin on the blood-brain barrier in acute ischemic stroke. Acta Neuropathol. 144, 305–337. doi: 10.1007/s00401-022-02452-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-022-02452-1</ArticleId><ArticleId IdType="pmc">PMC9288377</ArticleId><ArticleId IdType="pubmed">35752654</ArticleId></ArticleIdList></Reference><Reference><Citation>Stebbins M. J., Wilson H. K., Canfield S. G., Qian T., Palecek S. P., Shusta E. V. (2016). Differentiation and characterization of human pluripotent stem cell-derived brain microvascular endothelial cells. Methods 101, 93–102. doi: 10.1016/j.ymeth.2015.10.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymeth.2015.10.016</ArticleId><ArticleId IdType="pmc">PMC4848177</ArticleId><ArticleId IdType="pubmed">26518252</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabor-Godwin J. M., Ruller C. M., Bagalso N., An N., Pagarigan R. R., Harkins S., et al. . (2010). A novel population of myeloid cells responding to coxsackievirus infection assists in the dissemination of virus within the neonatal CNS. J. Neurosci. 30, 8676–8691. doi: 10.1523/JNEUROSCI.1860-10.2010</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1860-10.2010</ArticleId><ArticleId IdType="pmc">PMC2902258</ArticleId><ArticleId IdType="pubmed">20573913</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam P. E. (2006). Coxsackievirus myocarditis: Interplay between virus and host in the pathogenesis of heart disease. Viral Immunol. 19, 133–146. doi: 10.1089/vim.2006.19.133</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2006.19.133</ArticleId><ArticleId IdType="pubmed">16817756</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor D. J. R., Hamid S. M., Andres A. M., Saadaeijahromi H., Piplani H., Germano J. F., et al. . (2020). Antiviral effects of menthol on coxsackievirus b. Viruses 12 (4), 373. doi: 10.3390/v12040373</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12040373</ArticleId><ArticleId IdType="pmc">PMC7232514</ArticleId><ArticleId IdType="pubmed">32231022</ArticleId></ArticleIdList></Reference><Reference><Citation>Terskikh A., Fradkov A., Ermakova G., Zaraisky A., Tan P., Kajava A. V., et al. . (2000). “Fluorescent timer”: protein that changes color with time. Science 290, 1585–1588. doi: 10.1126/science.290.5496.1585</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.290.5496.1585</ArticleId><ArticleId IdType="pubmed">11090358</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Vliet E. A., Da Costa Araújo S., Redeker S., Van Schaik R., Aronica E., Gorter J. A. (2007). Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain 130, 521–534. doi: 10.1093/brain/awl318</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awl318</ArticleId><ArticleId IdType="pubmed">17124188</ArticleId></ArticleIdList></Reference><Reference><Citation>Volle R., Archimbaud C., Couraud P. O., Romero I. A., Weksler B., Mirand A., et al. . (2015). Differential permissivity of human cerebrovascular endothelial cells to enterovirus infection and specificities of serotype EV-A71 in crossing an in vitro model of the human blood-brain barrier. J. Gen. Virol. 96, 1682–1695. doi: 10.1099/vir.0.000103</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.000103</ArticleId><ArticleId IdType="pubmed">25711966</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiatr M., Figueiredo R., Stump-Guthier C., Winter P., Ishikawa H., Adams O., et al. . (2020). Polar infection of echovirus-30 causes differential barrier affection and gene regulation at the blood-cerebrospinal fluid barrier. Int. J. Mol. Sci. 21 (17), 6268. doi: 10.3390/ijms21176268</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21176268</ArticleId><ArticleId IdType="pmc">PMC7503638</ArticleId><ArticleId IdType="pubmed">32872518</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson H. K., Canfield S. G., Hjortness M. K., Palecek S. P., Shusta E. V. (2015). Exploring the effects of cell seeding density on the differentiation of human pluripotent stem cells to brain microvascular endothelial cells. Fluids Barriers CNS 12, 13. doi: 10.1186/s12987-015-0007-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12987-015-0007-9</ArticleId><ArticleId IdType="pmc">PMC4455681</ArticleId><ArticleId IdType="pubmed">25994964</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler E. A., Sengillo J. D., Sullivan J. S., Henkel J. S., Appel S. H., Zlokovic B. V. (2013). Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis. Acta Neuropathol. 125, 111–120. doi: 10.1007/s00401-012-1039-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1039-8</ArticleId><ArticleId IdType="pmc">PMC3535352</ArticleId><ArticleId IdType="pubmed">22941226</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong A. D., Ye M., Levy A. F., Rothstein J. D., Bergles D. E., Searson P. C. (2013). The blood-brain barrier: an engineering perspective. Front. Neuroeng 6, 7. doi: 10.3389/fneng.2013.00007</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneng.2013.00007</ArticleId><ArticleId IdType="pmc">PMC3757302</ArticleId><ArticleId IdType="pubmed">24009582</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C., Hawkins K. E., Doré S., Candelario-Jalil E. (2019). Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke. Am. J. Physiol. Cell Physiol. 316, C135–c153. doi: 10.1152/ajpcell.00136.2018</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00136.2018</ArticleId><ArticleId IdType="pmc">PMC6397344</ArticleId><ArticleId IdType="pubmed">30379577</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Zhou L., Bao L., Liu J., Zhu H., Lv Q., et al. . (2021). SARS-CoV-2 crosses the blood-brain barrier accompanied with basement membrane disruption without tight junctions alteration. Signal Transduct Target Ther. 6, 337. doi: 10.1038/s41392-021-00719-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00719-9</ArticleId><ArticleId IdType="pmc">PMC8419672</ArticleId><ArticleId IdType="pubmed">34489403</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>